Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-59
SponsorIndonesia University

About this trial

The goal of this clinical trial is to learn if acupuncture can play a role in reducing pain and improving the quality of life of post-radiotherapy nasopharyngeal cancer mucositis patients. The main questions it aims to answer are:

\- Do manual acupuncture and medication therapy affect pain intensity as measured by the visual analogue scale (VAS) in patients with oral mucositis compared with sham manual acupuncture and medication?

Participants will receive acupuncture therapy 2 times a week for 3 weeks

Eligibility criteria

Qualifiers

Subjects who have been proven by anatomical pathology examination to have a diagnosis of Nasopharyngeal Cancer.

Subjects with adult Nasopharyngeal Cancer aged 19 years - 59 years.

Nasopharyngeal Cancer Patients, who underwent bilateral Head and Neck radiotherapy.

Patients diagnosed with mucositis.

Disqualifiers

Nasopharyngeal Cancer patients who have distant metastases (based on the Tumor Node Metastasis (TNM) classification with the presence of metastases (M1)).

Subjects who still smoke and consume alcohol to date.

Patients have contraindications for manual acupuncture, namely the use of anti-coagulant drugs, the presence of infection or wounds at the puncture site, emergency conditions, and pregnancy.

There is a history of allergy to stainless steel materials.

Trial design

Treatments tested in this trial

  • Verum Acupuncture
  • Sham Acupuncture

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators